Quoin Pharmaceuticals, Ltd. 8-K

What Happened

• Quoin Pharmaceuticals, Ltd. (QNRX) announced its first quarter 2026 financial results and filed a Form 8-K on May 7, 2026 (Item 2.02). The company attached a press release dated May 7, 2026 as Exhibit 99.1 and incorporated that release by reference into the filing.

Key Details

• Filing date: May 7, 2026 (Form 8-K, Accession No. 0001104659-26-057140)
• Event reported: Results of operations and financial condition for Q1 2026 (Item 2.02)
• Exhibits included: Press Release (Exhibit 99.1) and Cover Page Interactive Data (Inline XBRL) (Exhibit 104)
• Disclosure note: The press release is incorporated by reference into the 8-K for the information provided

Why It Matters

• Quarterly financial results provide the latest information on the company’s revenue, expenses, and overall financial condition; investors should review the attached press release for specific figures (revenue, earnings/losses, cash position) and management commentary. This 8-K is a routine, material disclosure that may affect investment decisions and short-term trading, so shareholders and analysts will likely watch the press release and any subsequent SEC filings for detailed metrics and guidance.